IBDEI1WF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33391,1,3,0)
 ;;=3^Insomnia not d/t Substance/Known Physiol Condition
 ;;^UTILITY(U,$J,358.3,33391,1,4,0)
 ;;=4^F51.09
 ;;^UTILITY(U,$J,358.3,33391,2)
 ;;=^5003608
 ;;^UTILITY(U,$J,358.3,33392,0)
 ;;=H53.9^^182^2004^153
 ;;^UTILITY(U,$J,358.3,33392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33392,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,33392,1,4,0)
 ;;=4^H53.9
 ;;^UTILITY(U,$J,358.3,33392,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,33393,0)
 ;;=I89.0^^182^2004^107
 ;;^UTILITY(U,$J,358.3,33393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33393,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,33393,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,33393,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,33394,0)
 ;;=I87.1^^182^2004^152
 ;;^UTILITY(U,$J,358.3,33394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33394,1,3,0)
 ;;=3^Vein Compression
 ;;^UTILITY(U,$J,358.3,33394,1,4,0)
 ;;=4^I87.1
 ;;^UTILITY(U,$J,358.3,33394,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,33395,0)
 ;;=K08.8^^182^2004^57
 ;;^UTILITY(U,$J,358.3,33395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33395,1,3,0)
 ;;=3^Disorder of Teeth/Supporting Structures,Oth Specified
 ;;^UTILITY(U,$J,358.3,33395,1,4,0)
 ;;=4^K08.8
 ;;^UTILITY(U,$J,358.3,33395,2)
 ;;=^5008467
 ;;^UTILITY(U,$J,358.3,33396,0)
 ;;=N39.3^^182^2004^146
 ;;^UTILITY(U,$J,358.3,33396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33396,1,3,0)
 ;;=3^Stress Incontinence (Female/Male)
 ;;^UTILITY(U,$J,358.3,33396,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,33396,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,33397,0)
 ;;=R26.2^^182^2004^55
 ;;^UTILITY(U,$J,358.3,33397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33397,1,3,0)
 ;;=3^Difficulty in Walking NEC
 ;;^UTILITY(U,$J,358.3,33397,1,4,0)
 ;;=4^R26.2
 ;;^UTILITY(U,$J,358.3,33397,2)
 ;;=^5019306
 ;;^UTILITY(U,$J,358.3,33398,0)
 ;;=M54.6^^182^2004^148
 ;;^UTILITY(U,$J,358.3,33398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33398,1,3,0)
 ;;=3^Thoracic Spine Pain
 ;;^UTILITY(U,$J,358.3,33398,1,4,0)
 ;;=4^M54.6
 ;;^UTILITY(U,$J,358.3,33398,2)
 ;;=^272507
 ;;^UTILITY(U,$J,358.3,33399,0)
 ;;=E66.8^^182^2004^119
 ;;^UTILITY(U,$J,358.3,33399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33399,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,33399,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,33399,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,33400,0)
 ;;=E66.9^^182^2004^120
 ;;^UTILITY(U,$J,358.3,33400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33400,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,33400,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,33400,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,33401,0)
 ;;=F18.120^^182^2004^88
 ;;^UTILITY(U,$J,358.3,33401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33401,1,3,0)
 ;;=3^Inhalant Abuse w/ Intoxication,Uncomplicated
 ;;^UTILITY(U,$J,358.3,33401,1,4,0)
 ;;=4^F18.120
 ;;^UTILITY(U,$J,358.3,33401,2)
 ;;=^5003381
 ;;^UTILITY(U,$J,358.3,33402,0)
 ;;=G44.1^^182^2004^151
 ;;^UTILITY(U,$J,358.3,33402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33402,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,33402,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,33402,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,33403,0)
 ;;=G93.3^^182^2004^138
 ;;^UTILITY(U,$J,358.3,33403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33403,1,3,0)
 ;;=3^Postviral Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,33403,1,4,0)
 ;;=4^G93.3
 ;;^UTILITY(U,$J,358.3,33403,2)
 ;;=^5004181
 ;;^UTILITY(U,$J,358.3,33404,0)
 ;;=H53.9^^182^2004^154
 ;;^UTILITY(U,$J,358.3,33404,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1WF
